March 3, 2026 · Form 4 insider transaction
Oelschlager Kristen M sold 2,427 shares of Castle Biosciences, Inc. at $27.57 per share, a transaction worth $66.9K. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 2 days after the transaction.
Reflects the withholding of shares of the Issuer's common stock to satisfy tax withholding obligations in connection with the delivery of vested performance stock units reported on January 12, 2026.; Includes 965 shares acquired on February 27, 2026, under the Issuer's employee stock purchase plan.